T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing ...

The introduction of outpatient flat-rate payments approved today by the Swiss Federal Council poses significant risks for ...

In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in ...

Sweden’s Mendus (STO: IMMU), a clinical-stage drug developer, has announced the appointment of Dr Tariq Mughal as chief ...

US biotech Biohaven last week received a commitment from Oberland Capital to invest up to $600 million in the company. Also, ...

The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...

The global dermatological cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in first-quarter 2025 from ...

According to property advisor Knight Frank, venture capital (VC) funding into the UK life sciences sector reached £1.1 ...